Rongxi T. Wang
Beijing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Right parotid gland oncocytic carcinoma on [18F]FDG and [68Ga]Ga-FAPI-04 PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 21, 2026
Incidental Detection of Enterogastric Bile Reflux in 99mTc-Sestamibi Myocardial Perfusion Imaging.
Journal: Clinical nuclear medicine
Published: May 13, 2026
Antitumor efficacy and safety of locoregional [177Lu]Lu-RM26 radionuclide therapy in glioblastoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 15, 2026
68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.
Journal: Rheumatology (Oxford, England)
Published: January 22, 2026
Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3 Dual-Targeting Radioligand 177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 17, 2026
Preclinical and Initial Clinical Evaluation of 68Ga/177Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin αVβ3.
Journal: Molecular pharmaceutics
Published: December 17, 2025
Dual-targeted 68 Ga-NOTA-3P-TATE-RGD PET/CT in Radioactive-iodine Negative Differentiated Thyroid Cancer : An Exploratory Comparative Study With 18 F-FDG.
Journal: Clinical nuclear medicine
Published: December 10, 2025
Phase I dose-escalation study of [¹⁷⁷Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancer.
Journal: Theranostics
Published: November 10, 2025
[68Ga]Ga-P16-093 PET/CT in newly diagnosed prostate cancer: Histopathological validation and comparison with [68Ga]Ga-PSMA-11.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 18, 2025
Clinical Translation of a Dual Integrin-and GRPR-targeting PET Radiotracer 68 Ga-DOTA-RGD-RM26 in Glioma.
Journal: Clinical nuclear medicine
Published: July 20, 2025
Gastrin-Releasing Peptide Receptor Targeting PET/CT With 68 Ga-NOTA-RM26 in the Assessment of Glioma and Combined Multiregional Biopsies.
Journal: Clinical nuclear medicine
Published: January 14, 2025
Preclinical and First-in-Human Study of a Compact Radionuclide Labeled Self-Assembly Nanomedicine for Chemo-Radio-Theranostics of Cancer.
Journal: ACS nano
Published: January 13, 2025
Last Updated: 09/26/2026